Literature DB >> 21535308

Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'.

Sudhindra M Bhattacharya1, Ayan Jha.   

Abstract

AIM: Our objective was to study the prevalence and risk of metabolic syndrome (MS) among adolescent Indian girls with polycystic ovary syndrome (PCOS), compared to those without, as per the recent 'joint interim statement' criteria. We also aimed to compare the selected study parameters across PCOS adolescents with and without MS. MATERIAL &
METHODS: Cross-sectional data of 96 adolescent girls were retrospectively analyzed applying the 2009 'joint interim criteria' for MS. Fifty-one of them were diagnosed with PCOS as per the Androgen excess society criteria 2006. The remaining 45 adolescent girls (no androgen excess manifestations and regular cycles) formed the comparison group.
RESULTS: The prevalence of MS among adolescents with PCOS (60.78%; 95% CI = 50.78%, 70.78%) was significantly more compared to those without (P = 0.002). The odds ratio of MS among PCOS adolescents was 4.26 (95% CI = 1.79, 10.15). Only the mean waist circumference differed significantly between the PCOS and non-PCOS groups (P = 0.046). Interestingly, the contrast between the MS and non-MS subgroups of the PCOS adolescent sample produced significant differences in body mass index, waist circumference, blood pressure and biochemical parameters such as fasting plasma glucose, high-density lipoprotein-cholesterol and triglyceride levels.
CONCLUSION: Adolescent Indian girls with PCOS were reported to have 4.26 times more chances of developing MS compared to those without. Waist circumference was found to be the cheapest and simplest significant marker of MS. The study underlines the need for routine screening of MS among adolescent girls suffering from PCOS to reduce future co-morbidities.
© 2011 The Authors. Journal of Obstetrics and Gynaecology Research © 2011 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21535308     DOI: 10.1111/j.1447-0756.2010.01516.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  6 in total

Review 1.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 2.  Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome.

Authors:  Abm Kamrul-Hasan; Fatema Tuz Zahura Aalpona; Shahjada Selim
Journal:  touchREV Endocrinol       Date:  2021-04-28

Review 3.  Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Jamal Hallajzadeh; Maliheh Khoramdad; Nahid Karamzad; Amir Almasi-Hashiani; Ali Janati; Erfan Ayubi; Reza Pakzad; Mark J M Sullman; Saeid Safiri
Journal:  J Cardiovasc Thorac Res       Date:  2018-05-28

4.  How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.

Authors:  Xiaoxuan Zhao; Xiaoling Feng; Xinjie Zhao; Yuepeng Jiang; Xianna Li; Jingyun Niu; Xiaoyu Meng; Jing Wu; Guowang Xu; Lihui Hou; Ying Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

5.  Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.

Authors:  Iram Shabir; Mohd Ashraf Ganie; Mohd Afzal Zargar; Dilafroz Bhat; Mohd Muzzafar Mir; Aleem Jan; Zaffar Amin Shah; Vicar Jan; Riyaz Rasool; Andleeb Naqati
Journal:  Indian J Endocrinol Metab       Date:  2014-05

Review 6.  Poly Cystic Ovarian Syndrome: An Updated Overview.

Authors:  Samer El Hayek; Lynn Bitar; Layal H Hamdar; Fadi G Mirza; Georges Daoud
Journal:  Front Physiol       Date:  2016-04-05       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.